{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:28:45Z","timestamp":1776349725044,"version":"3.51.2"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2006,7,27]],"date-time":"2006-07-27T00:00:00Z","timestamp":1153958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,7,27]],"date-time":"2006-07-27T00:00:00Z","timestamp":1153958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2006,10,1]]},"DOI":"10.1038\/sj.leu.2404338","type":"journal-article","created":{"date-parts":[[2006,7,27]],"date-time":"2006-07-27T10:50:15Z","timestamp":1153997415000},"page":"1800-1808","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Janus kinase 2 (V617F) mutation status, signal transducer and activator of transcription-3 phosphorylation and impaired neutrophil apoptosis in myelofibrosis with myeloid metaplasia"],"prefix":"10.1038","volume":"20","author":[{"given":"R A","family":"Mesa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T S","family":"Lasho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Loegering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R F","family":"McClure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H L","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N T","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D P","family":"Steensma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S H","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,7,27]]},"reference":[{"key":"BF2404338_CR1","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","volume":"342","author":"A Tefferi","year":"2000","unstructured":"Tefferi A . Myelofibrosis with myeloid metaplasia. N Engl J Med 2000; 342: 1255\u20131265.","journal-title":"N Engl J Med"},{"key":"BF2404338_CR2","first-page":"264","volume":"2","author":"RA Mesa","year":"2003","unstructured":"Mesa RA . Myelofibrosis with myeloid metaplasia: therapeutic options in 2003. Curr Hematol Rep 2003; 2: 264\u2013270.","journal-title":"Curr Hematol Rep"},{"key":"BF2404338_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2141.1994.tb04969.x","volume":"88","author":"JT Reilly","year":"1994","unstructured":"Reilly JT . Pathogenesis of idiopathic myelofibrosis: present status and future directions [Review] [114 refs]. Br J Haematol 1994; 88: 1\u20138.","journal-title":"Br J Haematol"},{"key":"BF2404338_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054\u20131061.","journal-title":"Lancet"},{"key":"BF2404338_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","volume":"7","author":"RL Levine","year":"2005","unstructured":"Levine RL, Wadleigh M, Cools J . Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myelofibrosis with myeloid metaplasia. Cancer Cell 2005; 7: 387\u2013397.","journal-title":"Cancer Cell"},{"key":"BF2404338_CR6","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779\u20131790.","journal-title":"N Engl J Med"},{"key":"BF2404338_CR7","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1172\/JCI0215644","volume":"109","author":"CW Schindler","year":"2002","unstructured":"Schindler CW . JAK-STAT signaling in human disease. J Clin Invest 2002; 109: 1133\u20131137.","journal-title":"J Clin Invest"},{"key":"BF2404338_CR8","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1126\/science.1071545","volume":"296","author":"DS Aaronson","year":"2002","unstructured":"Aaronson DS, Horvath CM . A road map for those who don't know JAK-STAT. Science 2002; 296: 1653\u20131655.","journal-title":"Science"},{"key":"BF2404338_CR9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/35037710","volume":"407","author":"MO Hengartner","year":"2000","unstructured":"Hengartner MO . The biochemistry of apoptosis. Nature 2000; 407: 770\u2013776.","journal-title":"Nature"},{"key":"BF2404338_CR10","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/sj.leu.2402143","volume":"15","author":"MK White","year":"2001","unstructured":"White MK, McCubrey JA . Suppression of apoptosis: role in cell growth and neoplasia. Leukemia 2001; 15: 1011\u20131021.","journal-title":"Leukemia"},{"key":"BF2404338_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1172\/JCI113970","volume":"83","author":"JS Savill","year":"1989","unstructured":"Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C . Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989; 83: 865\u2013875.","journal-title":"J Clin Invest"},{"key":"BF2404338_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/jcp.1041560207","volume":"156","author":"K Muta","year":"1993","unstructured":"Muta K, Krantz SB . Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J Cell Physiol 1993; 156: 264\u2013271.","journal-title":"J Cell Physiol"},{"key":"BF2404338_CR13","first-page":"945","volume":"8","author":"R Buettner","year":"2002","unstructured":"Buettner R, Mora LB, Jove R . Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 2002; 8: 945\u2013954.","journal-title":"Clin Cancer Res"},{"key":"BF2404338_CR14","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.4161\/cbt.3.11.1172","volume":"3","author":"JV Alvarez","year":"2004","unstructured":"Alvarez JV, Frank DA . Genome-wide analysis of STAT target genes: elucidating the mechanism of STAT-mediated oncogenesis. Cancer Biol Ther 2004; 3: 1045\u20131050.","journal-title":"Cancer Biol Ther"},{"key":"BF2404338_CR15","doi-asserted-by":"publisher","first-page":"7486","DOI":"10.4049\/jimmunol.166.12.7486","volume":"166","author":"PK Epling-Burnette","year":"2001","unstructured":"Epling-Burnette PK, Zhong B, Bai F, Jiang K, Bailey RD, Garcia R et al. Cooperative regulation of Mcl-1 by Janus kinase\/stat and phosphatidylinositol 3-kinase contribute to granulocyte\u2013macrophage colony-stimulating factor-delayed apoptosis in human neutrophils. J Immunol 2001; 166: 7486\u20137495.","journal-title":"J Immunol"},{"key":"BF2404338_CR16","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1084\/jem.191.6.977","volume":"191","author":"M Horita","year":"2000","unstructured":"Horita M, Andreu EJ, Benito A, Arbona C, Sanz C, Benet I et al. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL. J Exp Med 2000; 191: 977\u2013984.","journal-title":"J Exp Med"},{"key":"BF2404338_CR17","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1182\/blood-2004-02-0749","volume":"105","author":"KJ Aichberger","year":"2005","unstructured":"Aichberger KJ, Mayerhofer M, Krauth MT, Skvara H, Florian S, Sonneck K et al. Identification of mcl-1 as a BCR\/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides. Blood 2005; 105: 3303\u20133311.","journal-title":"Blood"},{"key":"BF2404338_CR18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJM199802263380902","volume":"338","author":"M Silva","year":"1998","unstructured":"Silva M, Richard C, Benito A, Sanz C, Olalla I, Fernandez-Luna JL . Expression of Bcl-x in erythroid precursors from patients with polycythemia vera [see comments]. N Engl J Med 1998; 338: 564\u2013571.","journal-title":"N Engl J Med"},{"key":"BF2404338_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1600-0609.1999.tb01738.x","volume":"62","author":"MD Colovic","year":"1999","unstructured":"Colovic MD, Wiernik PH, Jankovic GM, Vidovic AD, Janosevic S, Basara NM . Circulating haemopoietic progenitor cells in primary and secondary myelofibrosis: relation to collagen and reticulin fibrosis. Eur J Haematol 1999; 62: 155\u2013159.","journal-title":"Eur J Haematol"},{"key":"BF2404338_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0022-1759(74)90109-4","volume":"5","author":"D English","year":"1974","unstructured":"English D, Andersen BR . Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll\u2013Hypaque. J Immunol Methods 1974; 5: 249\u2013252.","journal-title":"J Immunol Methods"},{"key":"BF2404338_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1182\/blood.V99.2.664","volume":"99","author":"BM Mow","year":"2002","unstructured":"Mow BM, Chandra J, Svingen PA, Hallgren CG, Weisberg E, Kottke TJ et al. Effects of the Bcr\/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro. Blood 2002; 99: 664\u2013671.","journal-title":"Blood"},{"key":"BF2404338_CR22","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1182\/blood-2002-07-2341","volume":"101","author":"TL Reeder","year":"2003","unstructured":"Reeder TL, Bailey RJ, Dewald GW, Tefferi A . Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia. Blood 2003; 101: 1981\u20131983.","journal-title":"Blood"},{"key":"BF2404338_CR23","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1182\/blood.V89.6.2098","volume":"89","author":"SH Kaufmann","year":"1997","unstructured":"Kaufmann SH, Svingen PA, Gore SD, Armstrong DK, Cheng YC, Rowinsky EK . Altered formation of topotecan-stabilized topoisomerase I-DNA adducts in human leukemia cells. Blood 1997; 89: 2098\u20132104.","journal-title":"Blood"},{"key":"BF2404338_CR24","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V93.2.674","volume":"93","author":"K Yamashita","year":"1999","unstructured":"Yamashita K, Takahashi A, Kobayashi S, Hirata H, Mesner Jr PW, Kaufmann SH et al. Caspases mediate tumor necrosis factor-alpha-induced neutrophil apoptosis and downregulation of reactive oxygen production. Blood 1999; 93: 674\u2013685.","journal-title":"Blood"},{"key":"BF2404338_CR25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1182\/blood.V85.2.532.532","volume":"85","author":"CH Homburg","year":"1995","unstructured":"Homburg CH, de Haas M, von dem Borne AE, Verhoeven AJ, Reutelingsperger CP, Roos D . Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 1995; 85: 532\u2013540.","journal-title":"Blood"},{"key":"BF2404338_CR26","doi-asserted-by":"publisher","first-page":"33968","DOI":"10.1074\/jbc.M203350200","volume":"277","author":"S Kobayashi","year":"2002","unstructured":"Kobayashi S, Takahashi A, Yamashita K, Takeoka T, Ohtsuki T, Suzuki Y et al. Calpain-mediated XIAP degradation in neutrophil apoptosis and its impairment in chronic neutrophilic leukemia. J Biol Chem 2002; 277: 33968\u201333977.","journal-title":"J Biol Chem"},{"key":"BF2404338_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"PK Smith","year":"1985","unstructured":"Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76\u201385.","journal-title":"Anal Biochem"},{"key":"BF2404338_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1006\/abio.2001.5313","volume":"296","author":"SH Kaufmann","year":"2001","unstructured":"Kaufmann SH . Reutilization of immunoblots after chemiluminescent detection. Anal Biochem 2001; 296: 283\u2013286.","journal-title":"Anal Biochem"},{"key":"BF2404338_CR29","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1074\/jbc.273.2.1058","volume":"273","author":"A Al-Shami","year":"1998","unstructured":"Al-Shami A, Mahanna W, Naccache PH . Granulocyte\u2013macrophage colony-stimulating factor-activated signaling pathways in human neutrophils. Selective activation of Jak2, Stat3, and Stat5b. J Biol Chem 1998; 273: 1058\u20131063.","journal-title":"J Biol Chem"},{"key":"BF2404338_CR30","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S0301-472X(99)00040-5","volume":"27","author":"M Yagisawa","year":"1999","unstructured":"Yagisawa M, Saeki K, Okuma E, Kitamura T, Kitagawa S, Hirai H et al. Signal transduction pathways in normal human monocytes stimulated by cytokines and mediators: comparative study with normal human neutrophils or transformed cells and the putative roles in functionality and cell biology. Exp Hematol 1999; 27: 1063\u20131076.","journal-title":"Exp Hematol"},{"key":"BF2404338_CR31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/sj.leu.2404007","volume":"20","author":"R McClure","year":"2006","unstructured":"McClure R, Mai M, Lasho T . Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders. Leukemia 2006; 20: 168\u2013171.","journal-title":"Leukemia"},{"key":"BF2404338_CR32","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V88.3.1013.1013","volume":"88","author":"B Dupriez","year":"1996","unstructured":"Dupriez B, Morel P, Demory J, Lai J, Simon M, Plantier I et al. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system [see comments]. Blood 1996; 88: 1013\u20131018.","journal-title":"Blood"},{"key":"BF2404338_CR33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0898-6568(98)00023-0","volume":"10","author":"RP de Groot","year":"1998","unstructured":"de Groot RP, Coffer PJ, Koenderman L . Regulation of proliferation, differentiation and survival by the IL-3\/IL-5\/GM-CSF receptor family. Cell Signal 1998; 10: 619\u2013628.","journal-title":"Cell Signal"},{"key":"BF2404338_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.leu.2401657","volume":"14","author":"JA McCubrey","year":"2000","unstructured":"McCubrey JA, May WS, Duronio V, Mufson A . Serine\/threonine phosphorylation in cytokine signal transduction. Leukemia 2000; 14: 9\u201321.","journal-title":"Leukemia"},{"key":"BF2404338_CR35","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1074\/jbc.M510943200","volume":"281","author":"M Um","year":"2006","unstructured":"Um M, Lodish HF . Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways. J Biol Chem 2006; 281: 5648\u20135656.","journal-title":"J Biol Chem"},{"key":"BF2404338_CR36","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0014-5793(00)02324-3","volume":"487","author":"C Akgul","year":"2001","unstructured":"Akgul C, Moulding DA, Edwards SW . Molecular control of neutrophil apoptosis. FEBS Lett 2001; 487: 318\u2013322.","journal-title":"FEBS Lett"},{"key":"BF2404338_CR37","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1365-2141.1993.tb08271.x","volume":"83","author":"E Juvonen","year":"1993","unstructured":"Juvonen E, Ikkala E, Oksanen K, Ruutu T . Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications. Br J Haematol 1993; 83: 192\u2013197.","journal-title":"Br J Haematol"},{"key":"BF2404338_CR38","first-page":"1382","volume":"290","author":"JF Prchal","year":"1974","unstructured":"Prchal JF, Axelrad AA . Letter: bone-marrow responses in polycythemia vera. N Engl J Med 1974; 290: 1382.","journal-title":"N Engl J Med"},{"key":"BF2404338_CR39","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.V83.8.2038.2038","volume":"83","author":"A Bedi","year":"1994","unstructured":"Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ . Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 1994; 83: 2038\u20132044.","journal-title":"Blood"},{"key":"BF2404338_CR40","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V83.5.1179.1179","volume":"83","author":"A McGahon","year":"1994","unstructured":"McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR, Cotter TG . BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 1994; 83: 1179\u20131187.","journal-title":"Blood"},{"key":"BF2404338_CR41","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1084\/jem.183.3.811","volume":"183","author":"N Carlesso","year":"1996","unstructured":"Carlesso N, Frank DA, Griffin JD . Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr\/Abl. J Exp Med 1996; 183: 811\u2013820.","journal-title":"J Exp Med"},{"key":"BF2404338_CR42","first-page":"247","volume":"13","author":"K Shuai","year":"1996","unstructured":"Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL . Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 1996; 13: 247\u2013254.","journal-title":"Oncogene"},{"key":"BF2404338_CR43","doi-asserted-by":"publisher","first-page":"31704","DOI":"10.1074\/jbc.271.49.31704","volume":"271","author":"RL Ilaria Jr","year":"1996","unstructured":"Ilaria Jr RL, Van Etten RA . P210 and P190(BCR\/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J Biol Chem 1996; 271: 31704\u201331710.","journal-title":"J Biol Chem"},{"key":"BF2404338_CR44","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1038\/sj.onc.1203486","volume":"19","author":"TS Lin","year":"2000","unstructured":"Lin TS, Mahajan S, Frank DA . STAT signaling in the pathogenesis and treatment of leukemias. Oncogene 2000; 19: 2496\u20132504.","journal-title":"Oncogene"},{"key":"BF2404338_CR45","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1182\/blood-2002-04-1204","volume":"101","author":"M Benekli","year":"2003","unstructured":"Benekli M, Baer MR, Baumann H, Wetzler M . Signal transducer and activator of transcription proteins in leukemias. Blood 2003; 101: 2940\u20132954.","journal-title":"Blood"},{"key":"BF2404338_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1172\/JCI9940","volume":"107","author":"PK Epling-Burnette","year":"2001","unstructured":"Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 2001; 107: 351\u2013362.","journal-title":"J Clin Invest"},{"key":"BF2404338_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1074-7613(00)80011-4","volume":"10","author":"R Catlett-Falcone","year":"1999","unstructured":"Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999; 10: 105\u2013115.","journal-title":"Immunity"},{"key":"BF2404338_CR48","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nrc906","volume":"2","author":"JE Darnell Jr","year":"2002","unstructured":"Darnell Jr JE . Transcription factors as targets for cancer therapy. Nat Rev Cancer 2002; 2: 740\u2013749.","journal-title":"Nat Rev Cancer"},{"key":"BF2404338_CR49","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1126\/science.1101637","volume":"305","author":"R Sordella","year":"2004","unstructured":"Sordella R, Bell DW, Haber DA, Settleman J . Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 2004; 305: 1163\u20131167.","journal-title":"Science"},{"key":"BF2404338_CR50","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/1097-4644(20001201)79:3<355::AID-JCB20>3.0.CO;2-0","volume":"79","author":"MJ Boucher","year":"2000","unstructured":"Boucher MJ, Morisset J, Vachon PH, Reed JC, Laine J, Rivard N . MEK\/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J Cell Biochem 2000; 79: 355\u2013369.","journal-title":"J Cell Biochem"},{"key":"BF2404338_CR51","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1053\/j.gastro.2005.03.010","volume":"128","author":"S Kobayashi","year":"2005","unstructured":"Kobayashi S, Werneburg NW, Bronk SF, Kaufmann SH, Gores GJ . Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells. Gastroenterology 2005; 128: 2054\u20132065.","journal-title":"Gastroenterology"},{"key":"BF2404338_CR52","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1158\/0008-5472.CAN-04-4281","volume":"65","author":"JV Alvarez","year":"2005","unstructured":"Alvarez JV, Febbo PG, Ramaswamy S, Loda M, Richardson A, Frank DA . Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors. Cancer Res 2005; 65: 5054\u20135062.","journal-title":"Cancer Res"},{"key":"BF2404338_CR53","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1182\/blood-2005-05-1889","volume":"106","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Teo SS, Buser AS, Brutsche M, Tiedt R, Tichelli A et al. Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2. Blood 2005; 106: 3374\u20133376.","journal-title":"Blood"},{"key":"BF2404338_CR54","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1056\/NEJMc051878","volume":"353","author":"A Tefferi","year":"2005","unstructured":"Tefferi A, Lasho TL, Gilliland G . JAK2 mutations in myeloproliferative disorders. N Engl J Med 2005; 353: 1416\u20131417.","journal-title":"N Engl J Med"},{"key":"BF2404338_CR55","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nm0605-595","volume":"11","author":"JE Darnell","year":"2005","unstructured":"Darnell JE . Validating Stat3 in cancer therapy. Nat Med 2005; 11: 595\u2013596.","journal-title":"Nat Med"},{"key":"BF2404338_CR56","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1038\/sj.onc.1208470","volume":"24","author":"J Sun","year":"2005","unstructured":"Sun J, Blaskovich MA, Jove R, Livingston SK, Coppola D, Sebti SM . Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 2005; 24: 3236\u20133245.","journal-title":"Oncogene"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404338.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404338","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404338.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:28:19Z","timestamp":1648780099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,27]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10,1]]}},"alternative-id":["BF2404338"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404338","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,27]]},"assertion":[{"value":"17 February 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}